The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
PHASE4CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
December 31, 2004
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
Conditions
Asthma
Interventions
DRUG
omalizumab
Trial Locations (1)
32610
University of Florida Asthma Research Lab, Gainesville
All Listed Sponsors
lead
University of Florida
OTHER
NCT00133042 - The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma | Biotech Hunter | Biotech Hunter